Drugs / Autologous Engineered Skin Substitute
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01655407 | Sep 2016 → Dec 2019 | — | Amarantus BioScience Holdings, Inc. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Engineered Skin Substitute | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01655407 ↗ |